LUNA MEDICAL TECHNOLOGIES INC
8-K, 2000-11-13
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: TRUST FOR INVESTMENT MANAGERS, 497, 2000-11-13
Next: LUNA MEDICAL TECHNOLOGIES INC, 8-K, EX-17, 2000-11-13




                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT



     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported): September 20, 2000



Nevada                           Luna Medical Technologies, Inc.  98-0207745
(State or other jurisdiction of  (Exact name of registrant as     (I.R.S.
incorporation or organization)   specified in its charter)        Employer
                                                                  Identification
                                                                  No.)


201-2001 McCallum Road, Abbotsford, British Columbia                 V2S 3N4
(Address of principal executive offices)                           (Zip Code)


                                 (866) 896-2633
              (Registrant's telephone number, including area code)


                              Thomas E. Stepp, Jr.
                              Stepp & Beauchamp LLP
                           1301 Dove Street, Suite 460
                         Newport Beach, California 92660
                                 (949) 660-9700
                            Facsimile: (949) 660-9010
                                   Page 1 of 3

<PAGE>

ITEM 5. OTHER EVENTS

On October 16,  2000,  the Board of  Directors  of the  Registrant  accepted the
resignation  of Mr. Stuart  McNeill as President and appointed Dr. James Swanney
as  President  and as a  director.  Mr.  McNeill  will  remain a director of the
Registrant.

Dr. Swanney was an associate  medical director with Pfizer Inc. Canada from 1978
to 1979. From 1979 to the present,  Dr. Swanney has practiced family medicine in
Abbotsford, British Columbia, Canada. Dr. Swanney served as medical director and
chairman of Impact Drug and Alcohol Treatment Program from 1989 through 1993 for
the treatment and support of substance abuse in adolescents. Dr. Swanney holds a
Diploma in Medical Jurisprudence from Glasgow University, Scotland.

Also on October 16, 2000,  the Board of Directors  of the  Registrant  appointed
Elizabeth  A.  Findlay as a  director  of  Registrant.  Ms.  Findlay  has been a
Registered  Nurse since 1976 and currently  serves as a Health Programs  Manager
for  the  Intensive  Care  and  Telemetry  Units,  Critical  Care  staffing  and
Respiratory  Department  at the MSA  General  Hospital  in  Abbotsford,  British
Columbia.  She is also an active member o the Registered  Nurses  Association of
British Columbia.

ITEM 6. RESIGNATION OF REGISTRANT'S DIRECTOR

On September  20,  2000,  the  Registrant  accepted  the  resignation  of Gordon
McDougall as one of the Registrant's Directors.


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of 1934,  each
Registrant  has  duly  caused  this  report  to  be  signed  on  behalf  of  the
undersigned, thereunto duly authorized.

                                            Luna Medical Technologies, Inc.


DATED: October 16, 2000                  By: /s/ Stuart McNeill
                                            ------------------------------
                                            Stuart McNeill, President


                                       2
<PAGE>

INDEX TO EXHIBITS

(1)     UNDERWRITING AGREEMENT
        Not Applicable.

(2)     PLAN OF ACQUISITION, REORGANIZATION, ARRANGEMENT, LIQUIDATION OR
        SUCCESSION
        Not Applicable.

(3)     INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING

(4)     INDENTURES
        Not Applicable.

(16)    LETTER RE: CHANGE IN CERTIFYING ACCOUNTANT
        Not Applicable.

(17)    LETTER RE: DIRECTOR RESIGNATION
        Letter of Resignation of Gordon McDougall dated September 20, 2000.

(20)    OTHER DOCUMENTS OR STATEMENTS TO SECURITY HOLDERS
        Not Applicable.

(23)    CONSENTS OF EXPERTS AND COUNSEL
        Not Applicable.

(24)    POWER OF ATTORNEY
        Not Applicable.

(27)    FINANCIAL DATA SCHEDULE
        Not Applicable.

(99)    ADDITIONAL EXHIBITS
        Not Applicable.


                                       3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission